RAPT Therapeutics, Inc.RAPTNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank88
3Y CAGR+52.9%
5Y CAGR+39.8%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+52.9%/yr
vs +25.1%/yr prior
5Y CAGR
+39.8%/yr
Recent acceleration
Acceleration
+27.9pp
Accelerating
Percentile
P88
Within normal range
vs 5Y Ago
5.3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$7.00M+12.2%
2024$6.24M-39.2%
2023$10.26M+424.5%
2022$1.96M+39040.0%
2021$5000.00-99.6%
2020$1.31M+1.5%
2019$1.29M+61.5%
2018$800000.00+270.4%
2017$216000.00-